Are you Dr. Ramirez?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
700 Childrens Dr
Columbus, OH 43205Phone+1 614-722-5315Fax+1 614-722-3033
Summary
- Dr. Nilsa Ramirez, MD is a board certified pathologist in Columbus, Ohio. She is currently licensed to practice medicine in Ohio and Michigan. She is affiliated with Nationwide Children's Hospital and The OSUCCC - James.
Education & Training
Detroit Medical Center/Wayne State UniversityResidency, Pathology-Anatomic and Clinical, 1985 - 1990
University of Puerto Rico School of MedicineClass of 1985
Certifications & Licensure
OH State Medical License 2001 - 2026
MI State Medical License 1988 - 2025- American Board of Pathology Anatomic Pathology
Clinical Trials
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Publications & Presentations
PubMed
- 1184 citationsIntegrated Genomic Characterization of Pancreatic Ductal AdenocarcinomaBenjamin J. Raphael, Ralph H. Hruban, Andrew J. Aguirre, Richard A. Moffitt, Jen Jen Yeh
Cancer Cell. 2017-08-14 - 1627 citationsComprehensive and Integrative Genomic Characterization of Hepatocellular CarcinomaAdrian Ally, Miruna Balasundaram, Rebecca Carlsen, Eric Chuah, Amanda Clarke
Cell. 2017-06-15 - 6098 citationsComprehensive molecular characterization of human colon and rectal cancerDonna M. Muzny, Matthew N. Bainbridge, Kyle Chang, Huyen Dinh, Jennifer Drummond
Nature. 2012-07-19
Press Mentions
Initiative Seeks to Improve Solid Tumor Treatment and Diagnosis in ChildrenApril 27th, 2022
Cloud-Based Digital Pathology Startup Deep Lens Exits Stealth Mode with $3.2 Million Seed FinancingOctober 12th, 2018
Biospecimen Core Resource Wins NIH Contract to Further Cancer ResearchFebruary 20th, 2018
